<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01741246</url>
  </required_header>
  <id_info>
    <org_study_id>1107004</org_study_id>
    <nct_id>NCT01741246</nct_id>
  </id_info>
  <brief_title>Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging</brief_title>
  <official_title>Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Allergan</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators hypothesize that chronic primary headaches are accompanied by a discrete
      pattern of brain metabolism and activity involving brain structures related to the
      development of acute exacerbations as well as pain modulation. Such structures include the
      brainstem, hypothalamus, and orbitofrontal cortex and can be defined using functional brain
      imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific aims of the study include:

        1. To determine the pattern of brain metabolism using positron emission tomography (PET)
           found in chronic migraine, episodic migraine and control patients.

        2. To determine changes of resting state brain networks using magnetic resonance imaging
           (MRI) between patients with chronic or episodic headache and healthy volunteers.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pattern of brain metabolism using positron emission tomography(PET).</measure>
    <time_frame>Estimated to be approximately three years post baseline</time_frame>
    <description>Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging to determine the pattern of brain metabolism.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of resting state brain networks using magnetic resonance imaging (MRI)</measure>
    <time_frame>Estimated to be approximately three years post baseline</time_frame>
    <description>Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging (MRI) To determine any changes of resting state brain networks</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">78</enrollment>
  <condition>Migraine</condition>
  <condition>Chronic Migraine</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Headache-free subjects.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Episodic migraine</arm_group_label>
    <description>Patients with less that 15 headache days per month that fulfill International Classification of Headache Disorders 2R (ICHD-2nd edition Revised)- criteria for Episodic Migraine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic migraine</arm_group_label>
    <description>Patients that fulfill International Classification of Headache Disorders (ICHD)-2R criteria for chronic migraine (more than 15 days per month).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with episodic migraine, chronic migraine and control patients. Definitions are
        taken for the International Classification of Headache Disorders-2nd Edition (see
        references).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-65

               -  No medical contraindication.

        Chronic headache group:

          -  Patients with chronic primary headaches who are experiencing phases with background
             pain as well as habitual pain exacerbations.

          -  Able to provide informed consent.

          -  Not pregnant or planning to become so, with a pregnancy test prior to scanning.

        Control group and Episodic migraine group:

          -  Patients with episodic migraine

          -  Able to provide informed consent.

          -  Not pregnant or planning to become so, with a pregnancy test prior to scanning.

        Exclusion Criteria:

          -  Taking a migraine preventive currently or in the last fifteen days.

          -  Known claustrophobia

          -  Patient is pregnant, planning to be pregnant, or becomes pregnant.

          -  Patients with metal implants.

          -  Patients who have had a study involving radiation within the one year prior to
             enrolling in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy Tso, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Goadsby, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amy Gelfand, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115 &amp; 94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol. 2002 Jun;15(3):287-95. Review.</citation>
    <PMID>12045727</PMID>
  </reference>
  <reference>
    <citation>Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998 Jul-Aug;38(7):497-506.</citation>
    <PMID>15613165</PMID>
  </reference>
  <reference>
    <citation>Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008 Aug 19;71(8):559-66. doi: 10.1212/01.wnl.0000323925.29520.e7.</citation>
    <PMID>18711108</PMID>
  </reference>
  <reference>
    <citation>Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDenBrink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, van den Maagdenberg AM, Goadsby PJ. Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci. 2006 Sep;24(6):1517-34. Review.</citation>
    <PMID>17004916</PMID>
  </reference>
  <reference>
    <citation>Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70. Review.</citation>
    <PMID>11807151</PMID>
  </reference>
  <reference>
    <citation>Afridi SK, Goadsby PJ. Neuroimaging of migraine. Curr Pain Headache Rep. 2006 Jun;10(3):221-4. Review.</citation>
    <PMID>18778577</PMID>
  </reference>
  <reference>
    <citation>Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayck RV, Coenen HH, Diener HC. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 Jul;1(7):658-60.</citation>
    <PMID>7585147</PMID>
  </reference>
  <reference>
    <citation>Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet. 2001 Mar 31;357(9261):1016-7.</citation>
    <PMID>11293599</PMID>
  </reference>
  <reference>
    <citation>Afridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005 Apr;128(Pt 4):932-9. Epub 2005 Feb 10.</citation>
    <PMID>15705611</PMID>
  </reference>
  <reference>
    <citation>Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005 Aug;62(8):1270-5.</citation>
    <PMID>16087768</PMID>
  </reference>
  <reference>
    <citation>Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007 Nov-Dec;47(10):1418-26.</citation>
    <PMID>18052951</PMID>
  </reference>
  <reference>
    <citation>Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache. 2008 Oct;48(9):1399-405. doi: 10.1111/j.1526-4610.2008.01274.x. Review.</citation>
    <PMID>19006557</PMID>
  </reference>
  <reference>
    <citation>Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006 Feb;129(Pt 2):543-50. Epub 2005 Dec 5.</citation>
    <PMID>16330505</PMID>
  </reference>
  <reference>
    <citation>Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, Erhard P, Tolle TR. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis. Pain. 2004 Jun;109(3):399-408.</citation>
    <PMID>15157701</PMID>
  </reference>
  <reference>
    <citation>Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006 Aug;123(3):231-43. Epub 2006 May 11. Erratum in: Pain. 2006 Nov;125(1-2):197.</citation>
    <PMID>16697110</PMID>
  </reference>
  <reference>
    <citation>Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82.</citation>
    <PMID>11209064</PMID>
  </reference>
  <reference>
    <citation>Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8. Epub 2002 Dec 27.</citation>
    <PMID>12506194</PMID>
  </reference>
  <reference>
    <citation>Calhoun VD, Adali T, Stevens MC, Kiehl KA, Pekar JJ. Semi-blind ICA of fMRI: A method for utilizing hypothesis-derived time courses in a spatial ICA analysis. Neuroimage. 2005 Apr 1;25(2):527-38.</citation>
    <PMID>15784432</PMID>
  </reference>
  <reference>
    <citation>Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004 Jan;127(Pt 1):220-30. Epub 2003 Nov 7.</citation>
    <PMID>14607792</PMID>
  </reference>
  <reference>
    <citation>Sprenger T, Ruether KV, Boecker H, Valet M, Berthele A, Pfaffenrath V, Wöller A, Tölle TR. Altered metabolism in frontal brain circuits in cluster headache. Cephalalgia. 2007 Sep;27(9):1033-42. Epub 2007 Jul 30.</citation>
    <PMID>17666083</PMID>
  </reference>
  <reference>
    <citation>Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160.</citation>
    <PMID>14979299</PMID>
  </reference>
  <reference>
    <citation>Frackowiak RS, Friston KJ. Functional neuroanatomy of the human brain: positron emission tomography--a new neuroanatomical technique. J Anat. 1994 Apr;184 ( Pt 2):211-25. Review.</citation>
    <PMID>8014115</PMID>
  </reference>
  <reference>
    <citation>Talairach J, Tournoux P. Coplanar Stereotaxic Atlas of the Human Brain. New York: Thieme; 1988.</citation>
  </reference>
  <reference>
    <citation>Valk PE, Delbeke D, Bailey DL, D.W. T, Maisey MN. Positron Emission Tomography: Springer; 2006.</citation>
  </reference>
  <reference>
    <citation>Sprenger T, Seifert CL, Valet M, Staehle KS, Tölle TR, Foerschler A, Zimmer C, Goadsby PJ. Abnormal Interictal Resting State Activity in Episodic Migraine. Presented at the 62nd Annual Meeting of the American Academy of Neurology 2010, Toronto.</citation>
  </reference>
  <reference>
    <citation>Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 Jun;26(6):742-6.</citation>
    <PMID>16686915</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2012</study_first_submitted>
  <study_first_submitted_qc>November 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2012</study_first_posted>
  <last_update_submitted>June 26, 2015</last_update_submitted>
  <last_update_submitted_qc>June 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Episodic migraine</keyword>
  <keyword>Chronic migraine</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>Positron emission tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

